Nokia has proclaimed a private 5G trial at a production plant at the Institute of Immunobiological Technology (Bio-Manguinhos) in Rio de Janeiro in Brazil as a connectivity springboard to enhance vaccine manufacturing. Bio-Manguinhos produces active pharmaceutical ingredients (APIs; not those ones) for vaccines for...
This site uses cookies to improve and personalize your experience and to display advertisements. This site may also include cookies from third parties. By using this site you consent to the use of cookies.Accept
